Single-Cell Analysis Transcriptomics Market Outlook Signals Expansion To $1.92 Billion Through 2030

The single-cell analysis transcriptomics market is on track for impressive expansion as advances in technology and growing applications continue to drive its evolution. From enhanced sequencing methods to cloud-based bioinformatics, this sector is becoming increasingly vital in biomedical research and personalized medicine. Here is an overview of its projected growth, major players, emerging trends, and key market segments.

Projected Market Size and Growth of the Single-Cell Analysis Transcriptomics Market
The market for single-cell analysis transcriptomics is anticipated to experience substantial growth, reaching a value of $1.92 billion by 2030. This reflects a robust compound annual growth rate (CAGR) of 12.2% during the forecast period. Several factors contribute to this expansion, including technological improvements in single-cell sequencing platforms, the adoption of cloud-enabled bioinformatics tools, heightened investments from pharmaceutical and biotech firms, broader use in personalized medicine, and the increasing incorporation of these technologies in hospital and diagnostic environments. Key market trends expected to shape the landscape include the rapid uptake of single-cell RNA sequencing, growth of microfluidics-based platforms, expanding clinical diagnostic applications, advances in drug discovery research, and sophisticated data analysis capabilities.

Download a free sample of the Single-Cell Analysis Transcriptomics market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24400&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Top Companies Leading the Single-Cell Analysis Transcriptomics Market
Prominent organizations currently driving the single-cell analysis transcriptomics market encompass Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Becton dic*kinson and Company, Agilent Technologies Inc., Sartorius Aktiengesellschaft, Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., 10x Genomics Inc., Abcam Limited, Novogene Co. Ltd., Standard BioTools Inc., Akoya Biosciences Inc., Parse Biosciences Inc., Cell Microsystems Inc., Mission Bio Inc., CYTENA GmbH, and Fluent BioSciences.

Significant Industry Acquisition Expanding Market Capabilities
In May 2024, Bruker Corporation, a US-based scientific instruments manufacturer, completed the acquisition of NanoString Technologies for approximately $392.6 million. This strategic move integrates NanoString's gene expression profiling and spatial transcriptomics solutions into Bruker's spatial biology portfolio, creating a highly complementary business. The acquisition is set to boost Bruker's capabilities in discovery and translational research, fostering innovation in both single-cell and spatial biology arenas. Notably, NanoString Technologies specializes in single-cell transcriptomics solutions and is also based in the US.

View the full Single-Cell Analysis Transcriptomics market report:
https://www.thebusinessresearchcompany.com/report/single-cell-analysis-transcriptomics-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Trends Showcasing Innovations in Single-Cell Analysis Transcriptomics
Leading companies in this market are concentrating on developing cutting-edge products like single-cell RNA sequencing kits that simplify workflows and provide deeper insights into cellular diversity. These kits allow researchers to isolate and analyze gene expression at the single-cell level, unveiling complex biological phenomena.

For example, in January 2024, Scale Biosciences, a US biotechnology firm focused on single-cell solutions, introduced the Single Cell RNA Kit v1.1-Extended Throughput. This innovative product supports processing up to 500,000 cells per run without requiring specialized instruments, significantly improving scalability, multiplexing, and cost efficiency in transcriptomic research.

Detailed Overview of Market Segments in Single-Cell Analysis Transcriptomics
This market report breaks down the single-cell analysis transcriptomics sector into several key segments:

1) Component: Equipment, Consumables, Software and Services
2) Technology: Single-Cell RNA Sequencing, Microfluidics-Based Techniques, Other Technologies
3) Application: Clinical Diagnostics, Developmental Biology, Drug Discovery, Other Applications
4) End-User: Academic and Research Institutions, Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies

Further subcategories include:

- Equipment: RNA Sequencers, PCR Machines, Microarray Instruments, Electrophoresis Systems, Flow Cytometers, Imaging Systems
- Consumables: Reagents and Kits, RNA Extraction Kits, Microarray Chips, Sequencing Chips, cDNA Synthesis Kits, Library Preparation Kits, Enzymes and Buffers
- Software and Services: Data Analysis Software, Transcriptome Assembly Software, Cloud-Based Solutions, Bioinformatics Services, Data Management Tools, Custom Analysis Services, Technical Support and Training

This comprehensive segmentation provides a clear framework for understanding the market's diverse product offerings and end-user applications.

Expanded capabilities in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.